Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh

Title
Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh
Authors
Keywords
-
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 11, Issue 1-2, Pages 36-44
Publisher
Springer Nature
Online
2010-07-30
DOI
10.1007/s11864-010-0120-6

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started